Companies: Identify two companies and one product produced by each company that directly relate to the NCT technical application your team has selected.

Trade Organizations: Identify one professional association or trade organization associated with the products your team identified. Include: its name, description of its mission, and number of people/companies involved.

Our Product: Propose and describe a new product or new process based on your team's NCT technical application.

Manufacturer: Via the Internet, locate a company that might be able to manufacture your team’s proposed product. Send the company an e-mail asking that someone in the company evaluate the product your team proposed. If your team is not able to obtain a response to your inquiry, provide on your website an example of the e-mail request you sent and the names of manufacturers to whom you sent the request.

Curis is a company that focuses on finding ways to regulate the pathways that repair and generate cells or tissue. They do this by somehow using proteins to adjust these pathways so that they send an adequate amount of signals. Curis has effectively treated kidney disease, neurological disorders, cancer, hair growth regulation, and cardiovascular disease using this process. One product that this company produces is called Hh small molecule agonist. It is used for certain neurological disorders such as ALS, Parkinson’s disease, and spinal cord damage.

Roche is a healthcare company that has been creating cures to a side variety of disorders and illnesses for several years.Cefteriaxone is a drug that that alters the amount of the production of Glutamate, a nerve cell messenger. It has been shown to significantly increase the life span in animals with Lou Gehrig's Disease.

Adopted September 24, 2004

The ASGT is a professional non-profit medical and scientific organization dedicated to the understanding, development and application of gene and related cell and nucleic acid therapies and the promotion of professional and public education in the field. ASGT is the largest medical professional organization representing researchers and scientists dedicated to discovering new gene therapies. The Society was established in 1996 and has already grown to almost 3,000 members. ASGT has an official journal, Molecular Therapy, which publishes scientific meritorious papers in the areas of gene transfer, gene regulation, gene discovery, cell therapy, experimental models, correction of genetic and acquired diseases, and clinical trials. Molecular Therapy is international in scope, publishing timely reviews, commentaries, and scientific correspondence. Molecular Therapy had a 2002 impact factor of 6.275 making it essential reading for researchers and clinicians in the field of molecular and cellular therapeutics and vaccination. Molecular Therapy is published by Elsevier on a monthly basis. ASGT holds an annual meeting each year, featuring scientific symposia, workshops, oral abstract presentations, exhibits and poster sessions. For more information on future annual meetings, go to www.asgt.org.

Harmonacknguyen is our product. The product would be used to treat people affected by ALS through the use of viruses. The viruses will be injected into the muscles of these patients. These viruses will inject synthetic RNA into the nucleus of all sarcomeres. Then, the muscle cell will produce the protein that the muscle lacks the production of. Slowing or stopping the ravages of ALS will greatly improve the quality of life of our patients. To see our product in more detail click here.